Magnus Schroeder, Ph.D

VP Process Development

Dr. Magnus Schroeder joined Avid as the Vice President of Process Development in May 2018. He most recently served as a director at AGC Biologics, formerly CMC Biologics, a global contract development and manufacturing organization, where he participated in the successful commercial launch of multiple products.  In that role, he successfully supported more than 25 client projects as they progressed toward first-in-human clinical trials, commercial product launch and ongoing commercial supply.  These efforts included creative resolution of complex challenges related to commercial processes that directly impacted a range of regulatory interactions and filings.  In directing AGC’s purification development team, Dr. Schroeder oversaw early-to-late phase development, process characterization, process control strategy, commercial process support and technology transfer/facility fit activities.  Prior to AGC Biologics, Dr. Schroeder held multiple senior level positions with CSL Limited, a global leader in the field of biotechnology.  During his tenure, he served as senior manager and senior scientist, leading process development activities for a range of CSL’s innovative biologics.

He has also held key process science positions with Dynavax Technologies, in which he was responsible for supporting process development, characterization and validation for multiple programs.

Dr. Schroeder earned his Ph.D. in biochemical engineering and his master of science in molecular biotechnology from Bielefeld University in Bielefeld, Germany.  He has previously served as a visiting scientist for protein purification at Rensselaer Polytechnic Institute and a visiting scientist for cell culture engineering at the University of Minnesota.

Close this popup.
We use cookies to improve your experience on our site. To find out more, read our Privacy Policy.